LAW vs LEGN

For growth investors, Legend Biotech Corporation (LEGN) is the stronger pick with 64.

5% revenue growth year-over-year, versus 8. 3% for CS Disco, Inc. (LAW). Analysts rate Legend Biotech Corporation (LEGN) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Legend Biotech Corporation (LEGN) delivered a total return of -4.

2%, compared to -90. 0% for CS Disco, Inc. (LAW). Over 10 years, the gap is even starker: LEGN returned -24. 0% versus LAW's -90. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CS Disco, Inc.

(LAW) is the lower-risk stock at 0. 67β versus Legend Biotech Corporation's 0. 76β — meaning LEGN is approximately 12% more volatile than LAW relative to the S&P 500.

By revenue growth (latest reported year), Legend Biotech Corporation (LEGN) is pulling ahead at 64.

5% versus 8. 3% for CS Disco, Inc. (LAW). On earnings-per-share growth, the picture is similar: CS Disco, Inc. grew EPS 22. 6% year-over-year, compared to -66. 0% for Legend Biotech Corporation. Over a 3-year CAGR, LEGN leads at 106. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CS Disco, Inc.

(LAW) is the more profitable company, earning -28. 3% net margin versus -28. 8% for Legend Biotech Corporation — meaning it keeps -28. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LEGN leads at -13. 3% versus -30. 7% for LAW. At the gross margin level — before operating expenses — LAW leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for LAW: 118.

4% to $9. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CS Disco, Inc.

(LAW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). Both have compounded well over 10 years (LAW: -90. 0%, LEGN: -24. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (LAW (Technology) and LEGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: LAW is a small-cap quality compounder stock; LEGN is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.